Miller GJ - Search Results

1

Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease.

Cooper JA, Miller GJ, Bauer KA, Morrissey JH, Meade TW, Howarth DJ, Barzegar S, Mitchell JP, Rosenberg RD. Cooper JA, et al. Among authors: miller gj. Circulation. 2000 Dec 5;102(23):2816-22. doi: 10.1161/01.cir.102.23.2816. Circulation. 2000. PMID: 11104738

2

Positive association between self-reported fatty food consumption and factor VII coagulant activity, a risk factor for coronary heart disease, in 4246 middle-aged men.

Connelly JB, Roderick PJ, Cooper JA, Meade TW, Miller GJ. Connelly JB, et al. Among authors: miller gj. Thromb Haemost. 1993 Aug 2;70(2):250-2. Thromb Haemost. 1993. PMID: 8236129 Clinical Trial.

3

Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.

Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Miller GJ, et al. Thromb Haemost. 1996 May;75(5):767-71. Thromb Haemost. 1996. PMID: 8725721

4

Risk of coronary heart disease and activation of factor XII in middle-aged men.

Miller GJ, Esnouf MP, Burgess AI, Cooper JA, Mitchell JP. Miller GJ, et al. Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2103-6. doi: 10.1161/01.atv.17.10.2103. Arterioscler Thromb Vasc Biol. 1997. PMID: 9351378

5

Activation of the coagulant pathway in cigarette smokers.

Miller GJ, Bauer KA, Cooper JA, Rosenberg RD. Miller GJ, et al. Thromb Haemost. 1998 Mar;79(3):549-53. Thromb Haemost. 1998. PMID: 9531038

6

Haemostatic factors in human peripheral afferent lymph.

Miller GJ, Howarth DJ, Attfield JC, Cooke CJ, Nanjee MN, Olszewski WL, Morrissey JH, Miller NE. Miller GJ, et al. Among authors: miller ne. Thromb Haemost. 2000 Mar;83(3):427-32. Thromb Haemost. 2000. PMID: 10744149

7

Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men.

Zito F, Drummond F, Bujac SR, Esnouf MP, Morrissey JH, Humphries SE, Miller GJ. Zito F, et al. Among authors: miller gj. Circulation. 2000 Oct 24;102(17):2058-62. doi: 10.1161/01.cir.102.17.2058. Circulation. 2000. PMID: 11044420

8

Does inflammatory proteolytic activity contribute to the increased factor IX activation peptide in men at high risk of coronary heart disease? A preliminary study.

Miller GJ, Bauer KA, Howarth DJ, Mitchell JP, Cooper JA. Miller GJ, et al. Thromb Haemost. 2002 Mar;87(3):415-20. Thromb Haemost. 2002. PMID: 11916072

9

Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII).

Miller GJ, Ireland HA, Cooper JA, Bauer KA, Morrissey JH, Humphries SE, Esnouf MP. Miller GJ, et al. J Thromb Haemost. 2008 Feb;6(2):259-67. doi: 10.1111/j.1538-7836.2008.02819.x. Epub 2007 Oct 29. J Thromb Haemost. 2008. PMID: 17973650 Free article.

10

Gemfibrozil reduces plasma prothrombin fragment F1 + 2 concentration, a marker of coagulability, in patients with coronary heart disease.

Wilkes HC, Meade TW, Barzegar S, Foley AJ, Hughes LO, Bauer KA, Rosenberg RD, Miller GJ. Wilkes HC, et al. Among authors: miller gj. Thromb Haemost. 1992 May 4;67(5):503-6. Thromb Haemost. 1992. PMID: 1519208 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters